EcoDrugPlus

Protein Kinase C, Eta

Ensembl ID : ENSMAUG00000001216
Gene Symbol: PRKCH
1 Cross references
237 Possible Orthologues:

Protein Kinase C, Gamma

Ensembl ID : ENSMAUG00000001309
Gene Symbol: PRKCG
1 Cross references
199 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSMAUG00000022213
Gene Symbol: PRKD1
4 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSMAUG00000010537
Gene Symbol: PRKD3
4 Cross references
270 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSMAUG00000002887
Gene Symbol: PRKACB
4 Cross references
299 Possible Orthologues:

Protein Kinase, Dna Activated, Catalytic Polypeptide

Ensembl ID : ENSMAUG00000013266
Gene Symbol: PRKDC
1 Cross references
184 Possible Orthologues:

Protein Kinase, Camp Dependent, Catalytic, Alpha

Ensembl ID : ENSMAUG00000004842
Gene Symbol: PRKACA
1 Cross references
283 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSMAUG00000012231
Gene Symbol: PPP3CA
4 Cross references
230 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSMAUG00000018808
Gene Symbol: PTK2B
4 Cross references
269 Possible Orthologues:

Protein Tyrosine Kinase 6

Ensembl ID : ENSMAUG00000021245
Gene Symbol: PTK6
4 Cross references
170 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSMAUG00000013671
Gene Symbol: PTPN11
4 Cross references
251 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSMAUG00000021522
Gene Symbol: PTPRB
4 Cross references
264 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).